genvec Reports First Quarter 2009 Financial Results – PR Newswire (press release)
May 7, 2009
|
genvec Reports First Quarter 2009 Financial Results
PR Newswire (press release), NY tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology to … |